WeVote
Log In

Bill

Bill

HB 94

Opioid-Associated Disease Prevention and Outreach Programs - Appeals and Membership of Standing Advisory Committee

2025 Regular Session

Maryland's HB 94 modifies the opioid prevention committee's appeals process and membership rules to improve program oversight and stakeholder participation.

Approved by the Governor - Chapter 27
0
WeVote Research Nonpartisan
Bill Summary · HB 94

Legislative bill overview

HB 94 modifies the appeals process and membership structure of the standing advisory committee that oversees Maryland's Opioid-Associated Disease Prevention and Outreach Programs. The bill adjusts how decisions made by the committee can be challenged and clarifies who can serve on this advisory body.

Why is this important

The advisory committee directly influences how opioid prevention and treatment resources are allocated in Maryland. Changes to its appeals process and membership could affect stakeholder participation, decision transparency, and the responsiveness of state opioid response programs to community needs.

Potential points of contention

  • Stakeholder access to appeals: Unclear whether the new appeals structure makes it easier or harder for affected communities, treatment providers, or other stakeholders to challenge committee decisions
  • Committee composition: Questions about whether revised membership requirements ensure diverse representation (e.g., people with lived experience of addiction, healthcare providers, law enforcement, community advocates)
  • Implementation clarity: The bill's operational details may lack specificity about timelines, appeal procedures, or decision-making standards that committees need to function effectively

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.